- Home
- ESPR vs BRY Comparison
ESPR vs BRY Comparison
Compare ESPR & BRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESPR
- BRY
- Stock Information
- Founded
- ESPR 2008
- BRY 1909
- Country
- ESPR United States
- BRY United States
- Employees
- ESPR N/A
- BRY N/A
- Industry
- ESPR Biotechnology: Pharmaceutical Preparations
- BRY Oil & Gas Production
- Sector
- ESPR Health Care
- BRY Energy
- Exchange
- ESPR Nasdaq
- BRY Nasdaq
- Market Cap
- ESPR 456.6M
- BRY 397.0M
- IPO Year
- ESPR 2013
- BRY N/A
- Fundamental
- Price
- ESPR $2.52
- BRY $4.23
- Analyst Decision
- ESPR Buy
- BRY Hold
- Analyst Count
- ESPR 3
- BRY 1
- Target Price
- ESPR $8.17
- BRY $5.00
- AVG Volume (30 Days)
- ESPR 5.2M
- BRY 1.5M
- Earning Date
- ESPR 11-07-2024
- BRY 11-07-2024
- Dividend Yield
- ESPR N/A
- BRY 11.58%
- EPS Growth
- ESPR N/A
- BRY 73.42
- EPS
- ESPR N/A
- BRY 1.06
- Revenue
- ESPR $295,451,000.00
- BRY $806,733,000.00
- Revenue This Year
- ESPR $198.22
- BRY N/A
- Revenue Next Year
- ESPR $25.83
- BRY $0.80
- P/E Ratio
- ESPR N/A
- BRY $3.98
- Revenue Growth
- ESPR 187.12
- BRY N/A
- 52 Week Low
- ESPR $1.16
- BRY $4.10
- 52 Week High
- ESPR $3.40
- BRY $8.88
- Technical
- Relative Strength Index (RSI)
- ESPR 64.07
- BRY 33.50
- Support Level
- ESPR $2.02
- BRY $4.10
- Resistance Level
- ESPR $2.60
- BRY $4.34
- Average True Range (ATR)
- ESPR 0.19
- BRY 0.27
- MACD
- ESPR 0.02
- BRY -0.04
- Stochastic Oscillator
- ESPR 89.04
- BRY 7.22
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.
About BRY Berry Corporation (bry)
Berry Corp (bry) is a western United States independent upstream energy company with a focus on the conventional, long-lived oil reserves in the San Joaquin basin of California. Its operating segments includes Exploration and Production (E&P) and Well Servicing and Abandonment. The company generates maximum revenue from the Exploration and Production (E&P) segment.